Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lobelia nummularia is a small, ground-matting, trailing herb of the family Campanulaceae, native to moist grasslands and open forests in Asia, particularly the Himalayas and Southeast Asia. Traditional medicinal uses include topical application of leaf and flower paste for eczema and skin diseases, as well as oral or topical use for stomach-ache, difficult urination, scabies, infected eyes, menstruation irregularity, spermatorrhoea, and other ailments. The fruit and leaves are sometimes used to treat sprue, swellings, and boils. While many Lobelia species are noted for their biologically active alkaloids (notably lobeline), specific pharmacological data and clinical mechanisms for Lobelia nummularia remain undocumented in modern scientific literature. The plant is used in folk medicine but not recognized as an approved pharmaceutical, and clinical data regarding its efficacy or safety are lacking[2][4][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lobelia nummularia.